Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 23Active not recruiting 10Terminated 4Withdrawn 2Unknown 1Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 18Sarcoma 5Other hematologic neoplasm 2Genitourinary 2Endocrine 2Thoracic 1Other solid neoplasm 1Other 1NET 1Lymphoid 1Gastrointestinal 1Dermatologic 1

Conditions

Colorectal Neoplasms 1057Stomach Neoplasms 802Carcinoma, Hepatocellular 785Pancreatic Neoplasms 577Rectal Neoplasms 449Colonic Neoplasms 405Esophageal Neoplasms 363Liver Neoplasms 225Esophageal Squamous Cell Carcinoma 144Neoplasms 134Cholangiocarcinoma 129Neoplasm Metastasis 117Breast Neoplasms 117Gastrointestinal Neoplasms 105Lung Neoplasms 76Biliary Tract Neoplasms 73Recurrence 61Prostatic Neoplasms 52Ovarian Neoplasms 49Barrett Esophagus 47Carcinoma, Non-Small-Cell Lung 44Anastomotic Leak 43Bile Duct Neoplasms 42Gastrointestinal Stromal Tumors 40Gallbladder Neoplasms 40Head and Neck Neoplasms 38Digestive System Neoplasms 35Anus Neoplasms 34Colonic Polyps 33Adenocarcinoma Of Esophagus 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Medulloblastoma × Gastrointestinal × Clear all
NCT05131763 2021-11-23

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Fudan University

Phase 1 Unknown
3 enrolled
CNSGastrointestinal

Colonic Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡